AnaptysBio

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$21.19
Previous Close
$21.40
Day Range
$20.94-$21.60
52W Range
$12.21-$36.54
Market Cap
$582.9M
Shares Short
9M

Financials

See more
Revenue (12 Mos)
$123.1M
Revenue Growth (YoY)
102.9%
Gross Profit (12 Mos)
-$40.6M
Diluted EPS
-$4.39

News

See more

Yahoo Finance • 27 days ago

Anaptys Announces Participation in September Investor Conferences

Yahoo Finance • 2 months ago

Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update

Yahoo Finance • 4 months ago

Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA

Yahoo Finance • 4 months ago

Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025

About

CEO
Mr. Daniel R. Faga
Address
10770 Wateridge Circle, San Diego, CA, United States, 92121-5801
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
136